"This book examines the treatment, diagnosis, prevention, and therapeutic and technological interventions of neurodegenerative disorders. It also describes programs and strategies that professional and family caregivers can implement to engage and improve the quality of life of persons suffering from cognitive impairment"--.

• Cover
• Title Page
• Copyright Page
• Editorial Advisory Board
• List of Contributors
• Table of Contents
• Preface
• Section 1: Causes and Prevention
  • Chapter 1: Amyloid Beta
  • Chapter 2: Lewy Body Disease
  • Chapter 3: Creutzfeldt-Jakob Disease
  • Chapter 4: Neuropathogenesis of Multiple Sclerosis and Huntington's Disease
  • Chapter 5: Environmental Aspects of Alzheimer's and Parkinson's Diseases Neuropathologies
  • Chapter 6: Dementia and Language Bilingualism Helps Ward Off Alzheimer's Disease
• Section 2: Early Detection and Diagnosis
  • Chapter 7: Cognitive Functions in the Geriatric Population
  • Chapter 8: The Early Diagnosis of Alzheimer's Disease
  • Chapter 9: Deep Learning in Early Detection of Alzheimer's
  • Chapter 10: Analysis of Biomedical Image for Alzheimer's Disease Detection
  • Chapter 11: Neuro-Imaging Machine Learning Techniques for Alzheimer's Disease Diagnosis
  • Chapter 12: Assessment of Cognitive-Communicative Functions in Persons With Mild Cognitive Impairment and Dementia of Alzheimer's Type
  • Chapter 13: Electroencephalogram Signal Analysis in Alzheimer's Disease Early Detection
  • Chapter 14: Early Detection of Electroencephalogram Temporal Events in Alzheimer's Disease
  • Chapter 15: Dealing With Noise and Partial Volume Effects in Alzheimer Disease Brain Tissue Classification by a Fuzzy-Possibilistic Modeling Based on Fuzzy-Genetic Initialization
  • Chapter 16: Early Detection of Parkinson's Disease
  • Chapter 17: Soft Computing-Based Early Detection of Parkinson's Disease Using Non-Invasive Method Based on Speech Analysis
  • Chapter 18: Tremor Identification Using Machine Learning in Parkinson's Disease
  • Chapter 19: QSAR and QAAR Studies on Mixtures of 3-(Benzylidene)Indolin-2-One Isomers as Leads to Develop PET Radiotracers for Detection of Parkinson's Disease
• Section 3: Immunotherapy, Pharmacotherapy, and Technological Treatments
  • Chapter 20: Alpha-Synucleinopathies
  • Chapter 21: Alzheimer's and Parkinson's Disease Novel Therapeutic Target
  • Chapter 22: MSDC-0160 and MSDC-0602 Binding with Human Mitochondrial Pyruvate Carrier (MPC) 1 and 2 Heterodimer
  • Chapter 23: User-Independent Detection for Freezing of Gait in Parkinson's Disease Using Random Forest Classification
  • Chapter 24: Stroke Rehabilitation and Parkinson's Disease Tremor Reduction Using BCIs Combined With FES
  • Chapter 25: Virtual Reality Therapeutic Environments in Autism Spectrum Disorder (ASD) and Alzheimer's
• Section 4: Management, Monitoring, and Improving Quality of Life
  • Chapter 26: Role of Diet, Functional Foods, and Nutraceuticals in Brain Disorders
  • Chapter 27: Dementia
  • Chapter 28: Environmental Landscape Design for Alzheimer's
  • Chapter 29: Monitoring System for Persons With Alzheimer's Disease via Video-Object Tracking
  • Chapter 30: Assessment of Graph Metrics and Lateralization of Brain Connectivity in Progression of Alzheimer's Disease Using fMRI
  • Chapter 31: IoT in the Field of Healthcare
  • Chapter 32: Assessment of Gait Disorder in Parkinson's Disease
  • Chapter 33: Using Technology to Empower People With Multiple Sclerosis (MS) to Make Shared Decisions About Managing Their Own Healthcare
• Index